NEW YORK, Sept. 6 – BioBridge Computing has finished developing its PIUMS protein identification software and has delivered the first unit to its research partner AstraZeneca, GenomeWeb has learned.

PIUMS—or Protein Identification Using Mass Spectrometry—is a fully automated software that includes Pepex, BioBridge’s peak extraction software. The two companies have been developing the software since they first struck a deal in July to develop the product.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.